9,23-diphenyl-16-(4-phenylquinazolin-2-yl)-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7(12),8,10,14,16,18(31),20(25),21,23,26,28,30(32)-pentadecaene

C56H33BN4 — CID 169047757

IUPAC9,23-diphenyl-16-(4-phenylquinazolin-2-yl)-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7(12),8,10,14,16,18(31),20(25),21,23,26,28,30(32)-pentadecaene
SMILESc1ccc(-c2ccc3c(c2)c2cccc4c2n3-c2cc(-c3nc(-c5ccccc5)c5ccccc5n3)cc3c2B4c2cccc4c5cc(-c6ccccc6)ccc5n-3c24)cc1
InChIInChI=1S/C56H33BN4/c1-4-14-34(15-5-1)37-26-28-48-43(30-37)40-21-12-23-45-54(40)60(48)50-32-39(56-58-47-25-11-10-20-42(47)53(59-56)36-18-8-3-9-19-36)33-51-52(50)57(45)46-24-13-22-41-44-31-38(35-16-6-2-7-17-35)27-29-49(44)61(51)55(41)46/h1-33H
InChIKeyPYYYLFRSWKFEMP-UHFFFAOYSA-N
MW772.72 g/mol
LogP11.64
Rot. Bonds4

About 9,23-diphenyl-16-(4-phenylquinazolin-2-yl)-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7(12),8,10,14,16,18(31),20(25),21,23,26,28,30(32)-pentadecaene

9,23-diphenyl-16-(4-phenylquinazolin-2-yl)-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7(12),8,10,14,16,18(31),20(25),21,23,26,28,30(32)-pentadecaene (PubChem CID 169047757) has the molecular formula C56H33BN4 and a molecular weight of 772.72 g/mol. Its IUPAC name is 9,23-diphenyl-16-(4-phenylquinazolin-2-yl)-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7(12),8,10,14,16,18(31),20(25),21,23,26,28,30(32)-pentadecaene.

Molecular Properties

Compound Name9,23-diphenyl-16-(4-phenylquinazolin-2-yl)-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7(12),8,10,14,16,18(31),20(25),21,23,26,28,30(32)-pentadecaene
PubChem CID169047757
Molecular FormulaC56H33BN4
Molecular Weight772.72 g/mol
Exact Mass772.28
IUPAC Name9,23-diphenyl-16-(4-phenylquinazolin-2-yl)-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7(12),8,10,14,16,18(31),20(25),21,23,26,28,30(32)-pentadecaene
SMILESc1ccc(-c2ccc3c(c2)c2cccc4c2n3-c2cc(-c3nc(-c5ccccc5)c5ccccc5n3)cc3c2B4c2cccc4c5cc(-c6ccccc6)ccc5n-3c24)cc1
InChIInChI=1S/C56H33BN4/c1-4-14-34(15-5-1)37-26-28-48-43(30-37)40-21-12-23-45-54(40)60(48)50-32-39(56-58-47-25-11-10-20-42(47)53(59-56)36-18-8-3-9-19-36)33-51-52(50)57(45)46-24-13-22-41-44-31-38(35-16-6-2-7-17-35)27-29-49(44)61(51)55(41)46/h1-33H
InChIKeyPYYYLFRSWKFEMP-UHFFFAOYSA-N
XLogP11.64
TPSA35.64 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds4
Heavy Atoms61
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500772.72
LogP ≤ 511.64
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 9,23-diphenyl-16-(4-phenylquinazolin-2-yl)-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7(12),8,10,14,16,18(31),20(25),21,23,26,28,30(32)-pentadecaene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 9,23-diphenyl-16-(4-phenylquinazolin-2-yl)-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7(12),8,10,14,16,18(31),20(25),21,23,26,28,30(32)-pentadecaene?
The IUPAC name of 9,23-diphenyl-16-(4-phenylquinazolin-2-yl)-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7(12),8,10,14,16,18(31),20(25),21,23,26,28,30(32)-pentadecaene (CID 169047757) is 9,23-diphenyl-16-(4-phenylquinazolin-2-yl)-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7(12),8,10,14,16,18(31),20(25),21,23,26,28,30(32)-pentadecaene.
What is the SMILES notation for 9,23-diphenyl-16-(4-phenylquinazolin-2-yl)-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7(12),8,10,14,16,18(31),20(25),21,23,26,28,30(32)-pentadecaene?
The canonical SMILES for 9,23-diphenyl-16-(4-phenylquinazolin-2-yl)-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7(12),8,10,14,16,18(31),20(25),21,23,26,28,30(32)-pentadecaene is c1ccc(-c2ccc3c(c2)c2cccc4c2n3-c2cc(-c3nc(-c5ccccc5)c5ccccc5n3)cc3c2B4c2cccc4c5cc(-c6ccccc6)ccc5n-3c24)cc1.
What is the InChIKey of 9,23-diphenyl-16-(4-phenylquinazolin-2-yl)-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7(12),8,10,14,16,18(31),20(25),21,23,26,28,30(32)-pentadecaene?
The InChIKey is PYYYLFRSWKFEMP-UHFFFAOYSA-N. The full InChI is InChI=1S/C56H33BN4/c1-4-14-34(15-5-1)37-26-28-48-43(30-37)40-21-12-23-45-54(40)60(48)50-32-39(56-58-47-25-11-10-20-42(47)53(59-56)36-18-8-3-9-19-36)33-51-52(50)57(45)46-24-13-22-41-44-31-38(35-16-6-2-7-17-35)27-29-49(44)61(51)55(41)46/h1-33H.
What are the key properties of 9,23-diphenyl-16-(4-phenylquinazolin-2-yl)-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7(12),8,10,14,16,18(31),20(25),21,23,26,28,30(32)-pentadecaene?
9,23-diphenyl-16-(4-phenylquinazolin-2-yl)-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7(12),8,10,14,16,18(31),20(25),21,23,26,28,30(32)-pentadecaene has a molecular weight of 772.72 g/mol, XLogP of 11.64, 4 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 9,23-diphenyl-16-(4-phenylquinazolin-2-yl)-13,19-diaza-1-boranonacyclo[16.12.1.12,6.119,26.07,12.014,31.020,25.013,33.030,32]tritriaconta-2(33),3,5,7(12),8,10,14,16,18(31),20(25),21,23,26,28,30(32)-pentadecaene is sourced from PubChem (CID 169047757), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).